en

PRODUCT DETAIL

Oktreotid Teva 20 mg

Code 1550D
MA number 56/0157/19-S
Product Form: plv inu 3x20 mg (liek.inj.skl.+3 striek.inj.napl.+3 ihla+3 adaptér)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU)
ATC:
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
H01C HYPOTHALAMIC HORMONES
H01CB Antigrowth hormone
H01CB02 Octreotide
Shelf life: 36
Container: glass vial
Route of admin.: Intramuscular use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 28.05.2019
SPC: SPC_Oktreotid Teva_3_2022.pdf  
PIL: PIL_Oktreotid Teva_07_2022.pdf  
Safety feature Yes
Data update: 26.01.2024
eu-flag.png sk-flag.png